GLOBEIMMUNE INC 소개
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.
Source: Wikipedia
산업Pharmaceuticals
본사Louisville, CO
설립1995
법적 형태C Corporation
상태운영 중
특허특허 20건
YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONSJP2019199484A · 2019
IMMUNOTHERAPEUTIC YEAST-MUC1 COMPOSITIONS AND USES THEREOFJP2019194261A · 2019
주요 수치
법적 정보
| 법인명 | GLOBEIMMUNE INC |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1245104SEC EDGAR에서 보기 ↗ |
| 등기 주소 | Louisville, CO |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 11월 14일 업데이트